The U.S. FDA inspected Lupin's Pithampur Unit-2 manufacturing facility from July 08 to July 17, 2025. The inspection closed with the issuance of a Form-483 with four observations.

Samsung Galaxy M36 5G review: A quality experience above everything else ...

ASX health stocks have rallied 4.9% over the past five days as the sector's largest company CSL lifts 6.3%. ... Read More The ...